ArticleCancers2020

Dual Inhibitory Action of a Novel AKR1C3 Inhibitor on Both Full-Length AR and the Variant AR-V7 in Enzalutamide Resistant Metastatic Castration Resistant Prostate Cancer.

Mona Kafka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.